Novartis appeals IP win for Pharmacor over blood pressure drug

Appeals 2025-01-20 11:42 pm By Christine Caulfield

Please login to bookmark

Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au